Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series
Case Reports in Dermatological Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crdm/9959087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Dermatological Medicine, online erschienen am 29.04.2026. Verfasst von Magesh Kirubakaran J P und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Shalya Tantra, Mahatma Gandhi Ayurveda College & Research Centre, Datta Meghe Institute of Higher Education & Research (Deemed to be Un…. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The management of pyoderma gangrenosum (PG) remains a formidable clinical challenge due to its complex, multipathway immunopathogenesis. Although conventional steroid therapy and advanced biologic agents have improved outcomes, a substantial proportion of patients, particularly those with severe, progressive ulceration, exhibit treatment‐refractory disease, highlighting a critical unmet need for novel strategies capable of network‐level immune modulation. To address this, we designed and implemented a self‐regulating, integrative meta‐therapeutic system centered on a nanostructured, herbo‐metallic core of traditionally processed mercury sulfide (HgS) called Linga Chenduram, a compound characterized by its stable crystalline lattice and a toxicokinetic profile favoring particulate clearance. This system synergistically combines the nanocore with adjunctive phytocompounds ( Allium sativum and Aloe vera ), a transient low‐dose glucocorticoid pulse, and an optimized anti‐inflammatory, antioxidant‐rich physiological milieu delivered within a stress‐free environment. In a cohort of four patients with PG refractory to conventional immunosuppressants, this 30‐day protocol elicited a rapid and profound clinical response. Objective metrics demonstrated a mean ulcer area reduction exceeding 61% by Day 30, progressing to complete and sustained re‐epithelialization in all subjects. This robust cutaneous healing occurred concurrently with the normalization of systemic inflammation (C‐reactive protein) and a significant restoration of functional capacity, evidenced by a mean improvement of 35 points on the Anterior Knee Pain Scale. Critically, clinical remission was maintained throughout a 6‐month surveillance period, establishing a definitive steroid‐sparing effect. We propose this multisystem improvements emerge from rational polypharmacology, wherein the nanoengineered HgS core serves as a pivotal immunomodulatory node, potentially engaging master regulatory pathways like NF‐κB to disrupt dysregulated cytokine circuitry. It transcends conventional combination therapy, introducing a paradigm for managing refractory autoinflammation through integrative systems and compelling a rigorous reappraisal of pharmaceutically refined traditional nanomedicines. This preliminary evidence establishes a compelling rationale for future research to deconstruct the system’s architecture and validate its therapeutic potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Shalya Tantra, Mahatma Gandhi Ayurveda College & Research Centre, Datta Meghe Institute of Higher Education & Research (Deemed to be University), Salod (H), Wardha, India.
- Department of Shalya Tantra, Sri Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpettai, India.
- Department of Ayurveda, Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya, Kanchipuram, India.
- Department of Shalakya Tantra, Government Ayurveda Medical College & Hospital, Kottar, Nagercoil, India.
- The Tamil Nadu Dr. M.G.R. Medical University, Chennai, India, tnmgrmu.ac.in.
- Department of Epidemiology, University of Washington, Seattle, Washington, USA, washington.edu.
ORCID-Profile: Magesh Kirubakaran J P
Zitieren
APA
J P, M. K., Shrivastav, P., R, S., K, S. K., Saito, A., & T, S. (2026). Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series. Case Reports in Dermatological Medicine, 2026(1). https://doi.org/10.1155/crdm/9959087
Vancouver
J P MK, Shrivastav P, R S, K SK, Saito A, T S. Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series. Case Reports in Dermatological Medicine. 2026;2026(1). doi:10.1155/crdm/9959087
BibTeX
@article{JP2026,
author = {J P, Magesh Kirubakaran and Shrivastav, Pooja and R, Sangeetha and K, Surya Kumar and Saito, Ayumi and T, Sakthivel},
title = {Achieving Steroid‐Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta‐Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series},
journal = {Case Reports in Dermatological Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crdm/9959087}
}
EUVIMED